287
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

A survey of long-term results with microwave energy device for treating axillary hyperhidrosis

, ORCID Icon, , ORCID Icon, &
Pages 49-51 | Received 02 Mar 2021, Accepted 14 Jul 2021, Published online: 19 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stamatios Gregoriou, Aikaterini Tsiogka, George Kontochristopoulos, Annamaria Offidani & Anna Campanati. (2022) Sofpironium bromide: an investigational agent for the treatment of axillary hyperhidrosis. Expert Opinion on Investigational Drugs 31:1, pages 15-21.
Read now

Articles from other publishers (3)

G. L. Grove, K. Togsverd‐Bo, J. F. B. Schwensen, N. W. Andersson, C. V. Nissen, C. Zachariae & M. Haedersdal. (2022) Impact of microwave thermolysis energy levels on patient‐reported outcomes for axillary hyperhidrosis and osmidrosis. Lasers in Surgery and Medicine 55:1, pages 105-115.
Crossref
Shuheng Wen, Kana Unuma, Yohsuke Makino, Hiroki Mori & Koichi Uemura. (2022) Fatal consequence after MiraDry® treatment: Necrotizing fasciitis complicated with streptococcal toxic shock syndrome. Legal Medicine 58, pages 102095.
Crossref
Punam DeAnupam DasSujata Sengupta. (2022) Axillary hyperhidrosis: An update. Cosmoderma 2, pages 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.